ThetaPal ThetaPal

Manufacturing / Biological Products, Except Diagnostic Substances

Replimune Group, Inc.

REPL

$13.29

+$0.28 (+2.13%)

Price as of Oct 9, 2026 16:42 UTC

1.4 B

Market Cap (Small Cap)

6%

IV Rank

74.8%

Implied Volatility

Nov 04

Next Earnings

Technical Signals as of Oct 7
Mixed
4 of 7

Trend

  • Above 20-day average $13.27
  • Above 50-day average $12.92
  • Above 200-day average $10.01 · +31.9%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 88d ago

Volume

  • Below-average volume 0.7x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

1.29

Bearish skew

Implied Volatility

74.8%

0% percentile

IV vs Realized

Options cheap

30d HV 219.3%

Options Heat Map

Delta-risk grid for REPL options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

2 buys 18 sells
Date Insider Title Type Shares Value Since Trade
Aug 20, 2026 Astley-Sparke Philip Gift 50,000 $0 -7.2%
Aug 17, 2026 Hill Emily Luisa Sell 9,256 $132,176 -8.7%
Aug 11, 2026 BAKER BROS. ADVISORS LP Buy 126,394 $1,524,299 +8.1%
Aug 11, 2026 BAKER BROS. ADVISORS LP Buy 2,609,946 $31,475,688 +8.1%
Aug 10, 2026 Schwendenman Andrew Sell 7,632 $98,987 +0.5%
Aug 10, 2026 Patel Sushil Sell 39,341 $510,253 +0.5%
Aug 10, 2026 Xynos Konstantinos Sell 11,447 $148,468 +0.5%
Aug 10, 2026 Hill Emily Luisa Sell 11,448 $148,481 +0.5%
Jun 01, 2026 Sarchi Christopher Sell 12,000 $110,880 +41.1%
May 18, 2026 Sarchi Christopher Sell 8,626 $43,820 +156.7%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 05, 2026 Q1 2027 -$0.70

Track REPL with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for REPL and your entire portfolio.